Alomfilimab (Anti-ICOS / CD278) | CD markers antibody | Read Reviews & Product Use Citations

Alomfilimab (Anti-ICOS / CD278) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS; CD278), with potential immunomodulating and antineoplastic activities. MW: 146.5 kD.

Purity & Quality Control

Batch: A276801 Purity: 99% Protein concentration: 6.52mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Alomfilimab (Anti-ICOS / CD278) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS; CD278), with potential immunomodulating and antineoplastic activities. MW: 146.5 kD.

References
[1] Sainson RCA, et al. Cancer Immunol Res. 2020;8(12):1568-1582.

References

[1] Sainson RCA, et al. Cancer Immunol Res. 2020;8(12):1568-1582.

Product Details

CAS No.	2378692-24-9
Molecular Weight	146.5
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field